PNU-159682 CAS: 202350-68-3, a potent Nemorubicin-derived anthracycline metabolite, excels as a DNA topoisomerase II inhibitor, surpassing Doxorubicin in ADC synthesis and emerging as a prime candidate for overcoming drug resistance through nanocell technology.
Payloads and Linker modified Payloads
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.
日本语
한국어
Français
Deutsch
España
Türkiye